Short Interest in Amedisys, Inc. (NASDAQ:AMED) Drops By 8.4%

Amedisys, Inc. (NASDAQ:AMED) was the target of a large drop in short interest during the month of October. As of October 15th, there was short interest totalling 1,640,000 shares, a drop of 8.4% from the September 30th total of 1,790,000 shares. Based on an average daily volume of 361,900 shares, the short-interest ratio is currently 4.5 days. Currently, 5.1% of the company’s shares are sold short.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on AMED shares. Cantor Fitzgerald reiterated a “neutral” rating and issued a $101.00 price objective on shares of Amedisys in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft cut Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price target for the company. in a research note on Monday, July 29th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $100.67.

Institutional Trading of Amedisys

A number of large investors have recently bought and sold shares of AMED. Innealta Capital LLC acquired a new position in shares of Amedisys in the second quarter valued at approximately $64,000. Covestor Ltd raised its holdings in shares of Amedisys by 134.2% during the first quarter. Covestor Ltd now owns 780 shares of the health services provider’s stock worth $72,000 after acquiring an additional 447 shares during the period. Signaturefd LLC lifted its position in Amedisys by 88.2% in the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock valued at $104,000 after acquiring an additional 530 shares in the last quarter. CWM LLC boosted its stake in Amedisys by 14.5% in the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after purchasing an additional 277 shares during the period. Finally, GAM Holding AG bought a new position in Amedisys during the 2nd quarter worth about $275,000. 94.36% of the stock is owned by institutional investors.

Amedisys Stock Down 0.1 %

Shares of Amedisys stock opened at $95.25 on Thursday. The company has a market capitalization of $3.11 billion, a P/E ratio of -148.83, a price-to-earnings-growth ratio of 1.89 and a beta of 0.78. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The business has a 50-day moving average of $96.93 and a two-hundred day moving average of $95.60. Amedisys has a 1 year low of $89.55 and a 1 year high of $98.95.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.